XML 39 R20.htm IDEA: XBRL DOCUMENT v3.20.4
Stock Plans
12 Months Ended
Dec. 31, 2020
Share-based Payment Arrangement [Abstract]  
Stock Plans
STOCK PLANS
STOCK OPTION AND AWARD PROGRAMS
Under our 2016 Incentive Compensation Plan (amended and restated effective May 5, 2020) and previously under our 2007 Incentive Compensation Plan (collectively, Incentive Compensation Plans), awards may be granted to employees and other key individuals who perform services for us and our participating subsidiaries. These awards may be in the form of stock options, restricted stock units or awards (collectively referred to as RSUs), portfolio grants (PGs) or other incentives or similar awards designed to meet the requirements of non-U.S. jurisdictions.

For our Incentive Compensation Plans, there were a total of 14 million, 9 million and 12 million common shares unissued and available for grant as of December 31, 2020, 2019, and 2018, respectively, as authorized by our Board of Directors and shareholders. We generally issue new common shares upon exercise of options and vesting of RSUs.
Stock-based compensation expense recognized in Salaries and employee benefits in the Consolidated Statements of Income was $247 million, $280 million and $288 million in 2020, 2019, and 2018, respectively, with corresponding income tax benefits of $59 million, $67 million and $69 million in those respective periods.
A summary of stock option and RSU activity as of December 31, 2020, and corresponding changes during the year, are as follows:
 Stock OptionsService-Based RSUsService and Performance-Based RSUs
(Shares in thousands)SharesWeighted-Average
Exercise Price
SharesWeighted-
Average Grant
Price
SharesWeighted-
Average Grant
Price
Outstanding as of December 31, 20194,172 $72.70 2,412 $91.42 3,392 $88.25 
Granted422 131.68 816 127.56 1,089 122.15 
Exercised/vested(822)53.50 (1,042)82.77 (1,193)78.52 
Forfeited(21)65.43 (108)105.32 (142)101.38 
Expired      
Outstanding as of December 31, 20203,751 83.59 2,078 $109.23 3,146 $103.08 
Options vested and expected to vest as of December 31, 20203,751 83.59 
Options exercisable as of December 31, 20202,706 $72.26 
Stock-based compensation expense is generally recognized ratably based on the grant-date fair value of the awards, net of expected forfeitures, over the vesting period. The vesting period is the shorter of the vesting schedule as defined in each award agreement or the date an individual will become eligible to retire. Retirement eligibility is dependent upon age and/or years of service.
STOCK OPTIONS
Each stock option has an exercise price equal to the market price of our common stock on the date of grant. Stock options generally vest on the third anniversary of the grant date and have a contractual term of 10 years from the date of grant.
The weighted-average remaining contractual life and the aggregate intrinsic value (the amount by which the fair value of our stock price exceeds the exercise price of the option) of the stock options outstanding, exercisable, and vested and expected to vest as of December 31, 2020, were as follows:
OutstandingExercisableVested and
Expected to Vest
Weighted-average remaining contractual life (in years)
5.34.25.3
Aggregate intrinsic value (millions)
$145 $132 $145 
As of December 31, 2020, there was $4 million of total unrecognized compensation cost related to unvested options, which will be recognized ratably over the weighted-average remaining vesting period of 1.5 years.
The fair value of each option is estimated on the date of grant using a Black-Scholes-Merton option-pricing model. The following weighted-average assumptions were used for options granted in 2020, 2019 and 2018:
202020192018
Dividend yield1.4 %1.5 %1.4 %
Expected volatility(a)
20 %24 %22 %
Risk-free interest rate1.6 %2.6 %2.7 %
Expected life of stock option (in years)(b)
7.17.17.1
Weighted-average fair value per option$25.83 $23.38 $23.17 
(a)The expected volatility is based on both weighted historical and implied volatilities of our common stock price.
(b)The expected life of stock options was determined using both historical data and expectations of option exercise behavior.

For stock options that were exercised during 2020, 2019 and 2018, the intrinsic value, based upon the fair value of our stock price at the date the options were exercised, was $47 million, $104 million and $104 million, respectively; cash received from the exercise of stock options was $44 million, $84 million and $87 million during those respective periods. The income tax benefit recognized in the Consolidated Statements of Income related to stock option exercises was $7 million, $18 million and $18 million in 2020, 2019 and 2018, respectively.
RESTRICTED STOCK UNITS/AWARDS
We grant RSUs that contain either a) service conditions or b) both service and performance conditions. RSUs containing only service conditions generally vest 25 percent per year beginning with the first anniversary of the grant date. RSUs containing both service and performance conditions generally vest on the third anniversary of the grant date, and the number of shares earned depends on the achievement of predetermined Company metrics. All RSU holders receive non-forfeitable dividends or dividend equivalents.

Beginning in 2019, a relative total shareholder return (r-TSR) modifier was added to the performance-based RSUs, so that our actual shareholder return relative to a competitive peer group is one of the performance conditions that determines the number of shares ultimately granted upon vesting.
The fair value of RSUs that do not include the r-TSR modifier, including those that contain only service conditions, is measured using our stock price on the grant date. The fair value of service and performance-based RSUs that include the r-TSR modifier is determined using a Monte Carlo valuation model with the following weighted-average assumptions for December 31:
20202019
Expected volatility(a)
19 %20 %
Risk-free interest rate1.4 %2.5 %
Remaining performance period (in years)
2.92.9
(a)The expected volatility is based on historical volatility of our common stock price.

As of December 31, 2020, there was $204 million of total unrecognized compensation cost related to non-vested RSUs, which will be recognized ratably over the weighted-average remaining vesting period of 2.0 years.
The weighted-average grant date fair value of RSUs granted in 2020, 2019 and 2018 was $124.47, $96.24 and $98.20, respectively.
For RSUs vested during 2020, 2019 and 2018, the total fair value, based upon our stock price at the date the RSUs vested, was $291 million, $286 million and $239 million, respectively.
LIABILITY-BASED AWARDS
In 2018, certain employees were awarded PGs and other incentive awards that can be settled with cash or equity shares at our discretion and final Compensation and Benefits Committee payout approval; beginning in 2019, we discontinued granting PGs. These awards earn value based on performance, market and/or service conditions, and vest over a period of three years.
PGs and other incentive awards are generally settled with cash and thus are classified as liabilities; therefore, the fair value is determined at the date of grant and remeasured quarterly as part of compensation expense over the vesting period. Cash paid upon vesting of these awards in 2020, 2019 and 2018 was $81 million, $81 million and $56 million, respectively.